Property:Inclusion criteria
This is a property of type Text.
R
Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial +
Hormone receptor positive invasive nonmetastatic breast cancer (Stage I-IIIB), had completed at least 8 weeks of anastrozole as adjuvant therapy prior to study entry, and were experiencing new or worsening musculoskeletal pain unrelated to any history of trauma;
serum 25OHD level between 10 and 29 ng/ml, serum calcium B10.3 mg/dl, and 24 h urine calcium excretion B250 mg/g creatinine +
Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer +
Undergone surgical resection of the colon or of rectal adenocarcinoma, and were on adjuvant or palliative treatment +
Ripamonti et al. (1998): A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation +
External beam radiotherapy treatment for head and neck cancer for the first time +
Rostock et al. (2013): Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Four-Arm Randomized Trial on the Effectiveness of Electroacupuncture +
Patients in remission after chemotherapy with taxanes, platinumderivatives, or vinca alkaloids and who presented with symptoms of CIPN +
Ryan et al. (2011): Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients +
Diagnosed with cancer, may have received ≥1 chemotherapy cycle, and were scheduled for at least three additional chemotherapy cycles, chemotherapy must have been given without concurrent radiation therapy or interferon and without planned interruption by radiation therapy or surgery, must have experienced nausea of any severity in any chemotherapy cycle before study enrollment, as well as scheduled to receive a 5-HT3 receptor antagonist (e.g., Zofran®, Kytril®, Navoban®, or Anzemet®) plus dexamathasone at all chemotherapy cycles +
Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients +
Diagnosed with noninflammatory breast cancer or carcinoma in situ and prescribed radiotherapy without concurrent chemotherapy at the University of Rochester Cancer Center +
S
Sahebjamee et al. (2015): Comparative Efficacy of Aloe vera and Benzydamine Mouthwashes on Radiation-induced Oral Mucositis: A Triple-blind, Randomised, Controlled Clinical Trial +
Diagnosis of head or neck cancer; age ≥18 years; Karnofsky performance > 70 (i.e. able to carry out normal activity and work) +
Sahebnasagh et al. (2017): Successful Treatment of Acute Radiation Proctitis with Aloe Vera: A Preliminary Randomized Controlled Clinical Trial +
Age ≥18 years; cancer in the pelvic area, radiotherapy and acute proctitis (ARP) +
Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial +
18–75 years, diagnosed with colorectal cancer, scheduled to receive oxaliplatin‑based regimens, more than 6 month life expectancy +
Salihah et al. (2016): The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting +
Women with a normal sense of smell; had a diagnosis of breast cancer; were receiving chemotherapy and experiencing nausea and/or vomiting of any severity (previously described in our earlier article13); were due to receive at least two further chemotherapy courses using similar chemotherapeutic agents +
Sanaati et al. (2016): Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer +
Patients between 20 and 60 years; histological diagnosis of breast cancer, history of receiving at least one chemotherapy injection, receiving single-day cycles of chemotherapy (each cycle separated from next by≥2 weeks); experiencing vomiting in previous sessions, and having normal values of hematologic and biomedical laboratory parameters. +
Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients +
Older than 18 years, had histologically documented diagnosis of head and neck cancer, had a Kanofsky performance status at least 70 +
Sangthawan et al. (2015): Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy +
Older than 18 years, had a histologically docu- mented diagnosis of head and neck cancer, and had a Karnof- sky Performance Status Scale score of at least 70 +
Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer +
Pathologically or cytologically proven adenocarcinoma of the prostate, metastatic disease (documented by computed tomograpghy, magnetic resonance imaging, or bone scan), disease progression after medical or surgical castration (documented by PSA, radiologic imaging of soft-tissue lesions, and/or bone scan;
life expectancy longer than 3 months, normal liver and kidney function, Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2, and testosterone lower than 50 ng/dL +
Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial +
Normal renal and hepatic function, life expectancy of more than one year +
Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) +
Post-menopausal women >18 years of age, with stage I-IIIA breast cancer, being treated with anastrozole, letrozole or exemestane for at least 30 days and experiencing aromatase inhibitor (AI)–associated musculoskeletal symptoms (AIMSS) at enrollment (prior to the run-in period) +
Sharp et al. (2009): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
? +
Sharp et al. (2010): A randomised, controlled trial of the psychological effects of reflexology in early breast cancer +
Female; over 18 years of age; newly diagnosed histologically proven early breast cancer (T1, T2 [<3 cm], N0, N1a, M0); received breast surgery; WHO status 0 or 1; willing to give written, informed consent; and able to complete questionnaires +
Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients +
Females with approved ovarian cancer who underwent primary cytoreductive surgery, willingness to participate in the study. +
Shooriabi et al. (2016): The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study +
Age over 18 years, a dose of radiation received over 4,500 cGy, the radiation received during the period 6 to 7 weeks, minor and major salivary glands involvement, one or two sides of the face in the field of radiation, and over the last three months of receiving radiation. +